Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Clinigen Group

    Client Virtual Booth

    CLINIGEN GROUP

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Clinigen Group
    unitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Pitcairn House, Crown Square, First Ave Burton-on-Trent DE14 2WW
    Telephone
    Telephone
    +44 (0) 1283 495 010
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.clinigengroup.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/clinigen-group
    Twitter
    Twitter
    https://twitter.com/Clinigen

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Clinigen launches NaviGATE: an educational programme for rare disease patients
    Clinigen launches NaviGATE: an educational programme for rare disease patients

    https://www.globenewswire.com//news-release/2023/09/12/2741483/0/en/Clinigen-launches-NaviGATE-an-educational-programme-for-rare-disease-patients-and-organisations.html

    GLOBENEWSWIRE
    12 Sep 2023
    Share Share
    Clinigen divests rights to four cancer support therapies to CNX Therapeutics
    Clinigen divests rights to four cancer support therapies to CNX Therapeutics

    https://www.globenewswire.com/news-release/2023/08/10/2722830/0/en/Clinigen-divests-global-rights-to-four-cancer-support-therapies-to-CNX-Therapeutics.html

    GLOBENEWSWIRE
    10 Aug 2023
    Share Share
    Clinigen divests Proleukin® to Iovance Biotherapeutics for £166.7 million
    Clinigen divests Proleukin® to Iovance Biotherapeutics for £166.7 million

    https://www.globenewswire.com/news-release/2023/01/23/2593186/0/en/Clinigen-divests-Proleukin-to-Iovance-Biotherapeutics-for-166-7-million.html

    GLOBENEWSWIRE
    23 Jan 2023
    Share Share
    Clinigen adds pharmacovigilance capabilities with acquisition of Navigator
    Clinigen adds pharmacovigilance capabilities with acquisition of Navigator

    https://www.globenewswire.com/news-release/2022/11/29/2563654/0/en/Clinigen-adds-pharmacovigilance-capabilities-with-acquisition-of-Drug-Safety-Navigator.html

    GLOBENEWSWIRE
    29 Nov 2022
    Share Share
    UK recall of Clinigen’s Mexiletine hydrochloride hard capsules
    UK recall of Clinigen’s Mexiletine hydrochloride hard capsules

    https://www.europeanpharmaceuticalreview.com/news/173469/uk-recall-of-clinigens-mexiletine-hydrochloride-hard-capsules/

    EUROPEAN PHARMACEUTICAL REVIEW
    05 Aug 2022
    Share Share
    Clinigen expands US site capacity for Clinical Supplies Management services
    Clinigen expands US site capacity for Clinical Supplies Management services

    https://www.globenewswire.com/news-release/2022/05/24/2448961/0/en/Clinigen-expands-US-site-capacity-in-response-to-growing-demand-for-Clinical-Supplies-Management-services.html

    GLOBENEWSWIRE
    24 May 2022
    Share Share
    Clinigen and Deciphera ink distribution deal for GIST drug
    Clinigen and Deciphera ink distribution deal for GIST drug

    https://www.thepharmaletter.com/article/clinigen-and-deciphera-ink-distribution-deal-for-gist-drug

    THEPHARMALETTER
    10 Feb 2022
    Share Share
    Humanigen Launches Managed Access Program for Lenzilumab
    Humanigen Launches Managed Access Program for Lenzilumab

    https://www.businesswire.com/news/home/20220209006129/en

    BUSINESSWIRE
    09 Feb 2022
    Share Share
    UK's Clinigen agrees to sweetened $1.8 billion Triton take-private deal
    UK's Clinigen agrees to sweetened $1.8 billion Triton take-private deal

    https://www.reuters.com/article/innovationNews/idUSKBN2JR0I3

    REUTERS
    18 Jan 2022
    Share Share
    Cancer drug specialist Clinigen strikes £1.2-billion deal to go private
    Cancer drug specialist Clinigen strikes £1.2-billion deal to go private

    https://www.theguardian.com/business/2021/dec/08/cancer-drug-specialist-clinigen-agrees-to-12bn-takeover-private-equity-firm-triton

    Julia Kollewe THEGUARDIAN
    08 Dec 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search